Therefore, we utilized the syngeneic MOC1 murine model of HPV-negative HNSCC both subcutaneously and orthotopically to elucidate how CXCR1/2 inhibition plus docetaxel reshapes the tumor immune microenvironment. This evidence concerns the gene CXCR1 and neoplasm.